Work

Risperidone versus olanzapine among patients with schizophrenia participating in supported employment: Eighteen-month outcomes

Year: 2017

Type: article

Study design: Clinical Trial

Source: Journal of Psychiatric Research

DOI: 10.1016/j.jpsychires.2017.09.008

Authors: Douglas L. Noordsy, Shirley M. Glynn, Catherine A. Sugar, Christopher D. O'Keefe, Stephen R. Marder

Institutions: Stanford Medicine, Stanford University, University of California, Los Angeles, VA Greater Los Angeles Healthcare System, Southern New Hampshire University

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: FORUM Pharmaceuticals, National Institute of Mental Health, Janssen Research and Development, Janssen Biotech

Awards: MANAGEMENT FOR RISK OF RELAPSE IN SCHIZOPHRENIA, G2753030133, G6496479936, G966693370

OpenAlex ID: W2753146186

FWCI: 0.435

Cites: 44

Cited by: 6

Related to: 10